From Lab to Market
From Breakthrough Science to Market Access
Integrated Finance, Operations, and Market Access Solutions for Biotech, Rare Disease, and Oncology Innovators.
From Lab to Market: The Challenge
Bringing life-changing therapies to patients is hard.
Scaling your company, securing investment, and navigating market access is even harder.
- Are you a scientist-founder struggling to build investor-ready operations?
- Facing the complexity of global pricing, reimbursement, and HTA?
- Need to align your clinical development with payer and regulatory expectations?
- Want to digitize your finance, supply chain, and evidence generation?
Our Solution
From Lab to Market – We empower Scientist-founders, Leaders of small and mid-sized biotechs to
- Build Scalable Business Operations:
- Finance transformation, ERP/FP&A, scenario modeling, and investor-grade reporting.
- Accelerate Market Access & Reimbursement:
- HTA, pricing, value proposition, and evidence generation for EU, North America, and Asia.
- Enable Digital Transformation:
- AI-powered tools for market access, launch tracking, and operational automation.
- Navigate Global Growth:
- Compliance, VAT, supply chain, and cross-border expansion support.
- Proven Track Record:
- Arena Pharmaceuticals, Ichnos Sciences, Stalicla, Santen Pharmaceuticals, and more.
- End-to-End Expertise:
- Finance, operations, market access, HEOR, and digital enablement.
- Personalized, Hands-On Support:
- We become an extension of your team.
